Identification of Novel Therapeutic Strategies for NUP98-NSD1-Positive AML By Drug Sensitivity Profiling

被引:0
|
作者
Kivioja, Jarno [1 ]
Kontro, Mika [2 ,3 ]
Thanasopoulou, Angeliki [4 ]
Majumder, Muntasir Mamun [5 ]
Yadav, Bhagwan [6 ]
Kuusanmaki, Heikki [5 ]
Parsons, Alun [6 ]
Schwaller, Juerg [4 ]
Porkka, Kimmo [7 ,8 ]
Heckman, Caroline A. [6 ]
机构
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Helsinki, Hematol Res Unit Helsinki, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Ctr Canc, Dept Hematol, Helsinki, Finland
[4] Univ Childrens Hosp, Basel, Switzerland
[5] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[6] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland
[7] Univ Helsinki, Dept Med, Hematol Res Unit Helsinki, Helsinki, Finland
[8] Univ Helsinki, Cent Hosp HUCH, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML
    Wenxin Du
    Zhimei Xia
    Zebin Luo
    Yichang Chen
    Shaowei Bing
    Wei Wang
    Xingya Zhang
    Zhan Zhou
    Jingying Zhang
    Ji Cao
    Bo Yang
    Qiaojun He
    Xuejing Shao
    Xiaojun Xu
    Meidan Ying
    Leukemia, 2023, 37 : 2286 - 2291
  • [32] Identification of Novel NUP98-NSD1 Fusion Transcripts in Adult DE NOVO Acute Myeloid Leukemia Patients with t(5;11)(q35;p15.4)
    Kivioja, J.
    Marti, J. Lopez
    Kontro, M.
    Kumar, A.
    Edgren, H.
    Parsons, A.
    Kallioniemi, O.
    Porkka, K.
    Heckman, C.
    ANNALS OF HEMATOLOGY, 2015, 94 : S78 - S78
  • [33] Application of drug sensitivity and resistance testing to identify novel therapeutic agents for Down syndrome patients with AML
    Patel, Apurvi R.
    Montoya, Justin J.
    Wai, Daniel H.
    Lee, David W.
    Arceci, Robert J.
    Azorsa, David O.
    CANCER RESEARCH, 2017, 77
  • [34] NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group
    Shiba, Norio
    Taki, Tomohiko
    Park, Myoung-ja
    Murata, Chisato
    Oki, Kentaro
    Ichikawa, Hitoshi
    Shimada, Akira
    Kanazawa, Takashi
    Sotomatsu, Manabu
    Tabuchi, Ken
    Adachi, Souichi
    Tawa, Akio
    Horibe, Keizo
    Tsuchida, Masahiro
    Hanada, Ryoji
    Tsukimoto, Ichiro
    Arakawa, Hirokazu
    Hayashi, Yasuhide
    BLOOD, 2011, 118 (21) : 641 - 641
  • [35] Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling
    Pemovska, Tea
    Kontro, Mika
    Yadav, Bhagwan
    Edgren, Henrik
    Eldfors, Samuli
    Szwajda, Agnieszka
    Almusa, Henrikki
    Bespalov, Maxim
    Ellonen, Pekka
    Elonen, Erkki
    Gjertsen, Bjorn T.
    Karjalainen, Riikka
    Kulesskiy, Evgeny
    Lagstroem, Sonja
    Lehto, Anna
    Lepistoe, Maija
    Lundan, Tuija
    Majumder, Muntasir Mamun
    Marti, Jesus Maria Lopez
    Mattila, Pirkko
    Murumaegi, Astrid
    Mustjoki, Satu
    Palva, Aino
    Parsons, Alun
    Pirttinen, Tero
    Raemet, Maria E.
    Suvela, Minna
    Turunen, Laura
    Vaestrik, Imre
    Wolf, Maija
    Knowles, Jonathan
    Aittokallio, Tero
    Heckman, Caroline A.
    Porkka, Kimmo
    Kallioniemi, Olli
    Wennerberg, Krister
    BLOOD, 2013, 122 (21)
  • [36] Identification of CARM1/PRMT4 as a novel therapeutic target for AML
    Greenblatt, Sarah M.
    Hamard, Pierre-Jacques J.
    Asai, Takashi
    Man, Na
    Martinez-Caja, Concepcion
    Liu, Fan
    Nimer, Stephen
    CANCER RESEARCH, 2017, 77
  • [37] Application of Drug Sensitivity and Resistance Testing to Identify Novel Therapeutic Agents for Down's Syndrome Patients with AML
    Patel, Apurvi
    Montoya, Justin
    Wai, Daniel
    Lee, David
    Azorsa, David
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S36 - S36
  • [38] Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms
    Aleshin, Alexey
    Santaguida, Marianne A.
    Spinner, Michael A.
    Sanders, Jeffrey N.
    Patterson, A. Scott
    Gekas, Christos
    Schaffert, Steven
    Greenberg, Peter L.
    BLOOD, 2018, 132
  • [39] A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia
    Jaju, RJ
    Fidler, C
    Haas, OA
    Strickson, AJ
    Watkins, F
    Clark, K
    Cross, NCP
    Cheng, JF
    Aplan, PD
    Kearney, L
    Boultwood, J
    Wainscoat, JS
    BLOOD, 2001, 98 (04) : 1264 - 1267
  • [40] Drug sensitivity profiling of BT-474 breast cancer cell line for identification of novel therapies targeting HER2-positive breast cancer
    Maki-Jouppila, Jenni H.
    Kahkonen, Tiina E.
    Suominen, Mari I.
    Halleen, Jussi M.
    Bernoulli, Jenni
    Saarela, Jani
    Fagerlund, Katja
    CANCER RESEARCH, 2018, 78 (13)